Skip to main content

Satsuma Pharmaceuticals, Inc.

STSADelisted Jun 8, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001692830

Satsuma Pharmaceuticals, Inc. was delisted on Jun 8, 2023; its insiders filed their last Form 4 on Jun 12, 2023; 31 institutions reported holding it in 13F filings for Q1 2023, worth $12.7M in total; no superinvestor held it.

13F holders, Q4 2022

Institutional positions in Satsuma Pharmaceuticals, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
33
−8 vs. Q3 2022
Shares held
19.8M
−4.61M (−18.9%) vs. Q3 2022
Total value
$17.8M
−$128.8M (−87.8%) vs. Q3 2022
New holders
9
8 more added
Sold out
17
11 more reduced

Compare with Q3 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting STSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2022: 33 institutions
Q1 2021: 61 institutionsQ2 2021: 60 institutionsQ3 2021: 45 institutionsQ4 2021: 35 institutionsQ1 2022: 36 institutionsQ2 2022: 32 institutionsQ3 2022: 41 institutionsQ4 2022: 33 institutionsQ1 2023: 31 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2022: $17.8M
Q1 2021: $136.3MQ2 2021: $167.4MQ3 2021: $108.3MQ4 2021: $103.6MQ1 2022: $87.7MQ2 2022: $94.2MQ3 2022: $146.7MQ4 2022: $17.8MQ1 2023: $12.7MQ2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding STSA and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 202331$12.7M
Q4 202233$17.8M
Q3 202241$146.7M
Q2 202232$94.2M
Q1 202236$87.7M
Q4 202135$103.6M
Q3 202145$108.3M
Q2 202160$167.4M
Q1 202161$136.3M

Institutions, Q4 2022

Shares, value and share of portfolio for each institution holding Satsuma Pharmaceuticals, Inc.; share changes are against Q3 2022.

Institutions holding STSA in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
BML Capital Management, LLC6,440,000$5.80M5.54%+6,440,000New
Ra Capital Management, L.P.5,914,252$5.32M0.11%00.0%Unchanged
NEA Management Company, LLC2,992,958$2.69M0.15%−150,000−4.8%Reduced
Vanguard Group Inc920,517$828.5K0.00%+11,127+1.2%Added
Driehaus Capital Management LLC816,902$735.2K0.01%−897,144−52.3%Reduced
Geode Capital Management, LLC409,108$368.0K0.00%+217,663+113.7%Added
Two Sigma Investments, LP291,946$262.8K0.00%+281,417+2,672.8%Added
Acadian Asset Management LLC275,069$246.0K0.00%+275,069New
Renaissance Technologies LLC254,100$229.0K0.00%+244,100+2,441.0%Added
Dimensional Fund Advisors LP231,417$209.0K0.00%−44,849−16.2%Reduced
Nan Fung Group Holdings Ltd177,900$160.1K0.11%00.0%Unchanged
Millennium Management LLC174,994$157.0K0.00%+112,878+181.7%Added
Two Sigma Advisers, LP152,300$137.1K0.00%+117,500+337.6%Added
BlackRock Inc.136,300$122.7K0.00%−15,880−10.4%Reduced
Ikarian Capital, LLC136,059$122.5K0.05%00.0%Unchanged
Marquette Asset Management, LLC78,551$70.7K0.02%+78,551New
Bridgeway Capital Management, LLC70,300$63.3K0.00%−45,000−39.0%Reduced
State Street Corp62,236$56.0K0.00%00.0%Unchanged
Chicago Partners Investment Group LLC63,863$54.3K0.00%+63,863New
Susquehanna International Group, LLP54,419$49.0K0.00%+42,369+351.6%Added
Northern Trust Corp42,232$38.0K0.00%−37−0.1%Reduced
Simplex Trading, LLC32,565$29.0K0.00%−35,258−52.0%Reduced
Two Sigma Securities, LLC24,972$22.5K0.00%+24,972New
Bank of America Corp18,271$16.4K0.00%−224−1.2%Reduced
Barclays PLC15,893$14.3K0.00%−203,009−92.7%Reduced
Blair William & Co15,000$13.5K0.00%+15,000New
Boothbay Fund Management, LLC11,968$10.8K0.00%00.0%Unchanged
Morgan Stanley11,183$10.1K0.00%−212,633−95.0%Reduced
Citadel Advisors LLC9,912$8.92K0.00%+9,912New
Group One Trading, L.P.572$5150.00%+572New
Wells Fargo & Company182$1640.00%+48+35.8%Added
FMR LLC45$410.00%+45New
Citigroup Inc8$70.00%−6,577−99.9%Reduced
Commodore Capital LP0$00.00%−3,711,286−100.0%Sold out
Samlyn Capital, LLC0$00.00%−2,929,195−100.0%Sold out
TPG GP A, LLC0$00.00%−1,885,939−100.0%Sold out
Vivo Capital, LLC0$00.00%−1,232,394−100.0%Sold out
Ameriprise Financial Inc0$00.00%−796,865−100.0%Sold out
EAM Investors, LLC0$00.00%−149,029−100.0%Sold out
Walleye Capital LLC0$00.00%−93,672−100.0%Sold out
Caption Management, LLC0$00.00%−90,000−100.0%Sold out
Bank of New York Mellon Corp0$00.00%−16,262−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−11,300−100.0%Sold out
Marshall Wace, LLP0$00.00%−10,123−100.0%Sold out
Virtu Financial LLC0$00.00%−10,096−100.0%Sold out
Advisor Group Holdings, Inc.0$00.00%−1,000−100.0%Sold out
Federated Hermes, Inc.0$00.00%−100−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−110−100.0%Sold out
BNP Paribas Arbitrage, SA0$00.00%−59−100.0%Sold out
UBS Group AG0$00.00%−27−100.0%Sold out